about us

Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare. 

our story

Cancer has impacted the lives of many of our friends and family.  Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data.  Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale.  If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught.  We see that by taking a quantitative approach, the data generated by our tools  benefits preclinical research, clinical trials, and ultimately patients.

the leadership team

Claire Weston, PhD
CEO

Ami Lau

VP of Operations

Mitul Shah
Head of Product

Andrew Han

Finance Business Partner

Erika Hong

Histology Manager

Pearl Mensah

Business Development Dir.

scientific advisory board

Cory Roberts
CEO, ProPath

Christine Valladolid
Executive Director, Kaiser

Our Partners

We are proud to partner with the following organizations

News & Articles

Latest research, in the news, or at events.

➞ View All News & Articles

Contact Us

Reach out to our team

Learn how data powered pathology can enhance your research, clinical trial, or pathology workflow.

Reveal Biosciences is improving global healthcare with a new generation of data powered pathology to characterize and detect disease.

Follow Us

Linkedin-in Twitter Facebook-f Instagram

contact

Reveal Biosciences, Inc.

6760 Top Gun St, Suite 110

San Diego, CA 92121

navigation

services

Copyright © 2023 All rights reserved. 

Claire Weston

Founder & CEO

Dr. Claire Weston is an accomplished and dedicated
scientific leader with a track record of success in cancer research. She was awarded a Ph.D. in Cell Biology from Cambridge University in the U.K. and has led teams and projects focused on cancer
biomarkers in both large pharma and start-up
environments. Claire founded Reveal Biosciences in 2012 and the company has since demonstrated strong year-on-year growth. She has authored numerous peer-reviewed publications in leading journals including Science, and is a respected
member of multiple professional organizations
including the Digital Pathology Association.

Ami Lau

Director of Operations

Ami Lau is a senior member of the Reveal team and leads Operations and Human Resources. Ami is responsible for client satisfaction, efficient operations and maintaining a collaborative and innovative company culture. With 15 years of previous Human Resources Management experience at National Instruments and other large companies, Ami is focused on scalability as Reveal continues to grow.  Ami holds a Master’s degree in Management from the College of Notre Dame and a Bachelor’s degree in Industrial Psychology from the University of Maryland.

Andrew Han

Finance Business Partner

Andrew Han is our Finance Business Partner and a member of the Reveal leadership team. He plays a key role in partnering with our business to connect commercial and operational processes to optimize visibility and planning, identify opportunities, and provide strategic decision support. He has over 12 years of experience working for large publicly traded companies across multiple leadership roles within Corporate Finance. Andrew is currently attending the University of Southern California Marshall School of Business to complete his MBA.

Erika Hong

Histology Manager

Erika is the Histology manager within the Reveal team. She provides the technical knowledge, expertise, leadership and judgment required to support Reveal’s mission. Erika leads the histology team in the application of various histology methods including IHC, IF, ISH, and special stains. She received her B.S. degree in Biochemistry and Cell Biology from University of California, San Diego.

Pearl Mensah

Business Development Director

Pearl Mensah is Reveal’s Business Development Director, working to expand business opportunities for quantitative histopathology and AI projects with key clients in large pharmaceutical and biotech companies through consultative sales. She brings over 7 years of experience in the life sciences industry. Pearl started her career at Villanova University as a Women’s Basketball player, where she earned her BA degree in Philosophy, MA in Educational Leadership and Administration and an MS in Human Resource Development.

Cory Roberts

CEO, ProPath

Cory is the President and CEO of ProPath, one of the largest physician-owned pathology companies in the US. ProPath comprises nearly 50 physicians and over 400 employees serving patients in 45 states plus several foreign countries. ProPath has a nationwide sales force and medically directs 25 hospitals. Cory is also an advisor to Glenview Capital Management (London & New York), and serves on the Graduate Medical Education Committee for the College of American Pathologists. He has published numerous peer-reviewed papers, book chapters, and has testified before Congress regarding the laboratory workflow shortage.

Christine Valladolid

Executive Direction, Kaiser Permanente

Christine is the Executive Director of Enterprise Leadership and Organizational Effectiveness at Kaiser Permanente. She has been with KP for more than a decade and has served in organizational strategy, technology governance, and program management. Before joining KP, she worked in technology consulting at Capgemini. She holds a doctorate in Organizational Leadership from Pepperdine University, an M.B.A. from Vanderbilt University and a B.A. from Penn State. She is an adjunct professor at the University of Redlands and teaches courses in the university’s Healthcare Administration and Project Management programs.

Pathology Revealed

Sign up to receive updates on the latest AI-powered pathology breakthroughs, access digital pathology resources, and more.